Overview for Regulatory Affairs Personnel on the Requirements for Submission of Clinical Data for NDAs

June 19, 2006

Drug Information Association, Online Oct 5 2006 This webinar is designed to give Regulatory Affairs personnel insight into FDA management expectations for submitting clinical data for NDAs.

Organized by:			Drug Information Association
Invited Speakers:			ARMANDO OLIIVA,, MD Associate Director for Policy Office of New Drugs CDER, FDA GARY GENSIINGER Director, Regulatory Review Support Staff Office of Business Process Support CDER, FDA FREDERIICK E.. WOOD,, PHD Principal Consultant Octagon Research Solutions GABRIIELE FIISCHER Director, Global Regulatory Submissions Bayer Pharmaceuticals Corp.

Deadline for Abstracts:			-

Registration:			http://www.diahome.org/product/11418/06246.pdf
E-mail:			dia@diahome.org

events